Actively Recruiting
Evaluation of the Efficacy of Electroacupuncture in the Treatment of Functional Dyspepsia
Led by Yi Liang · Updated on 2025-08-29
180
Participants Needed
4
Research Sites
76 weeks
Total Duration
On this page
Sponsors
Y
Yi Liang
Lead Sponsor
Z
Zhejiang University of Science and Technology
Collaborating Sponsor
AI-Summary
What this Trial Is About
Brief Summary Template for the Study: The goal of this clinical trial is to evaluate whether electroacupuncture can treat functional dyspepsia (FD) in adult participants aged 18 to 65 years, including both males and females, who have been diagnosed with functional dyspepsia based on the Rome IV criteria. The main questions it aims to answer are: * Does 5 Hz electroacupuncture improve symptoms in functional dyspepsia patients? * Does 100 Hz electroacupuncture improve symptoms in functional dyspepsia patients? * Are there differences in the efficacy between 5 Hz and 100 Hz electroacupuncture in treating functional dyspepsia and its subtypes (PDS and EPS)? Researchers will compare the effects of 5 Hz electroacupuncture, 100 Hz electroacupuncture, and sham electroacupuncture to determine which approach provides more significant symptom relief and whether different frequencies have varying impacts on FD subtypes. Participants will: * Receive electroacupuncture treatment at specific acupoints (such as Liangmen, Tianshu, Zusanli, and Xiajuxu) for 30-minute sessions, 3 times a week for 4 weeks. * Be randomly assigned to one of the following groups: 5 Hz electroacupuncture, 100 Hz electroacupuncture, or sham electroacupuncture (control). * Have their functional dyspepsia symptoms, quality of life, and any adverse effects monitored and evaluated throughout the study.
CONDITIONS
Official Title
Evaluation of the Efficacy of Electroacupuncture in the Treatment of Functional Dyspepsia
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Diagnosed with functional dyspepsia based on Rome IV diagnostic criteria.
- Aged 18 to 80 years, inclusive, with no gender restrictions.
- Normal endoscopy results within the past year showing no structural explanation for symptoms.
- No acupuncture treatment in the last month.
- Not participating in any other clinical trials in the past 2 months.
- Able to understand and provide informed consent.
You will not qualify if you...
- Presence of serious or malignant diseases such as cirrhosis, heart failure, or gastrointestinal tumors that could explain dyspepsia symptoms.
- Positive for Helicobacter pylori infection based on C-13 urea breath test or gastric biopsy.
- History of gastrointestinal surgery (excluding laparoscopic and other minimally invasive surgeries).
- Recent use (within 2 weeks) of medications affecting dyspepsia, including prokinetics, proton pump inhibitors, antacids, or antidepressants.
- Presence of severe mental or physical conditions such as dementia or illiteracy that could interfere with study participation.
- Severe coagulation disorders.
- Substance abuse or alcohol dependence.
- Pregnant or breastfeeding women.
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 4 locations
1
The Third Affiliated Hospital of Zhejiang Chinese Medicinal University
Hangzhou, None Selected, China, 310053
Actively Recruiting
2
Hangzhou First People's Hospital
Hangzhou, Zhejiang, China, 310053
Actively Recruiting
3
Sir Run Run Shaw Hospital, affiliated with the Zhejiang University School of Medicine
Hangzhou, Zhejiang, China, 310053
Actively Recruiting
4
The First Affiliated Hospital of Zhejiang Chinese Medical University
Hangzhou, Zhejiang, China, 310053
Actively Recruiting
Research Team
Y
Yi Liang, Doctor
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
DOUBLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
3
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here